Earlymarket — 2021 Investments

1 investments dated 2021 · listed companies and verified rows first · show all

Nanoverynanovery.co.ukJun 2021

Nanovery develops DNA-based nanorobotic sensors that quantify nucleic acid sequences, such as RNA therapeutics and biomarkers, in liquid samples using a standard plate reader.

BiotechDeep TechHealthtechMedical DevicesLondon, GB

Jerzy Kozyra(CEO)in Mun Ching Lee(Cofounder)in

Co-investorsEntrepreneur First Northstar Ventures

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.